ADM: Adalimumab; AUC 0-∞ ... ADM 40 mg/week, sc. ADM 80 mg/week, sc. Weinblatt et al. (2003) (ARMADA) 24 weeks ADM 20 mg e2w, sc. + MTX ADM 40 mg e2w, sc. + MTX ADM 80 mg e2w, sc.

One of the induction therapy studies also used adalimumab 40-/20-mg and 80-/40-mg regimens for induction therapy. [29] Both regimens resulted in a statistically significant reduction of at least ...

Off-label TNF-α inhibitor dosing or usage typically consists of 80 mg adalimumab administered weekly or infusion of infliximab or its biosimilars. Golimumab and certolizumab have not been studied ...

he was given adalimumab, a recombinant human IgG1 monoclonal TNF antagonist, starting with an induction course of 160 mg administered subcutaneously followed by 80 mg 2 weeks later, with the ...